摘要
目的分析精益化管理对提高抗菌药物治疗前病原学送检率的价值。方法选取2021年1月—2023年9月暨南大学附属顺德医院92766例住院患者为研究对象,根据不同就诊时间分组,2021年1—6月送检标本17278例次为对照组,2021年7—12月送检标本17794例次为干预后第一阶段组,2022年1—12月送检标本31813例次为干预后第二阶段组,2023年1—9月送检标本27130例次为干预后第三阶段组。比较各组患者的抗菌药物送检情况。结果对照组、干预后第一阶段组、干预后第二阶段组、干预后第三阶段组抗菌药物治疗前病原学送检率分别为7.25%、13.86%、16.49%、27.63%,组间比较、两两比较均差异有统计学意义(P<0.001)。对照组、干预后第一阶段组、干预后第二阶段组、干预后第三阶段组医院感染诊断相关病原学送检率分别为85.16%、88.89%、90.53%、97.24%,组间比较差异有统计学意义(P<0.05),其中干预后第三阶段组分别高于对照组、干预后第一阶段组、干预后第二阶段组,差异有统计学意义(P<0.05)。各组联合使用重点药物前病原学送检率组间比较、两两比较均差异无统计学意义(P>0.05)。结论精益化管理对提升住院患者应用抗菌药物治疗前的病原学送检率具有显著作用,能够进一步强化抗菌药物的科学化、高效化管理,确保抗菌药物得到规范使用。
Objective To analyze the value of lean management in improving the etiological testing rate before antibacterial drug treatment.Methods A total of 92766 inpatients from the Affiliated Shunde Hospital of Jinan University from January 2021 to September 2023 were selected as the research subjects.They were grouped according to different visiting times.17278 specimens sent for examination from January to June 2021 were the control group,17794 specimens sent for examination from July to December 2021 were the first stage group after intervention,31813 specimens sent for examination from January to December 2022 were the second stage group after intervention,and 27130 specimens sent for examination from January to September 2023 were the third stage group after intervention.Compare the submission of antibacterial drugs for examination in each group of patients.Results The etiological testing rates before antibacterial drug treatment in the control group,the first stage group after intervention,the second stage group after intervention and the third stage group after intervention were 7.25%,13.86%,16.49%and 27.63%respectively,there were statistically significant differences between the groups and pairwise comparisons(P<0.001).The etiological testing rates of pathogenic factors related to hospital infection diagnosis in the control group,the first stage group after intervention,the second stage group after intervention and the third stage group after intervention were 85.16%,88.89%,90.53%and 97.24%respectively,there was a statistically significant difference among the groups(P<0.05).Among them,the third stage group after intervention were respectively higher than the control group,the first stage group after intervention and the second stage group after intervention,and the differences were statistically significant(P<0.05).There were no statistically significant differences in the etiological testing rates before the combined use of key drugs among groups or pairwise comparisons(P>0.05).Conclusion Lean management has a significant effect on improving the etiological testing rate of inpatients before the application of antibacterial drugs for treatment.It can further strengthen the scientific and efficient management of antibacterial drugs and ensure the standardized use of antibacterial drugs.
作者
陈小兰
王安芝
杨海清
叶杰
邓风清
符国华
吴庆斌
温旺荣
CHEN Xiaolan;WANG Anzhi;YANG Haiqing;YE Jie;DENG Fengqing;FU Guohua;WU Qingbin;WEN Wangrong(Department of Clinical Laboratory,the Affiliated Shunde Hospital of Jinan University,Foshan Guangdong 528305,China;Department of Critical Care Medicine,the First Affiliated Hospital of Jinan University,Guangzhou Guangdong 510630,China;Department of Nosocomial Infection Management,the Affiliated Shunde Hospital of Jinan University,Foshan Guangdong 528305,China;Department of Information Centre,the Affiliated Shunde Hospital of Jinan University,Foshan Guangdong 528305,China)
出处
《中国卫生标准管理》
2025年第11期159-164,共6页
China Health Standard Management
关键词
精益化管理
抗菌药物
病原学送检率
医院感染
临床诊疗
用药合理性
lean management
antibacterial drug
etiological testing rate
hospital infection
clinical diagnosis and treatment
rationality of medication use
